Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
E4Comfort Study I
2019-001289-14Phase 3Completed
- Sponsor
- Estetra SRL
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of estetrol in menopause and hot flash (3 arms), sponsored by Estetra SRL. Primary endpoints: Change in frequency of moderate to severe vasomotor symptoms at week 4, Change in frequency of moderate to severe vasomotor symptoms at week 12 and 2 more. Started Sep 2019; status: completed.
02
Drugs
estetrol
03
Conditions
menopausehot flash
Beyond the preview
Go deeper on 2019-001289-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001289-14.